Major depressive disorder (MDD) is defined differently across genetic research studies and
this may be a key source of heterogeneity. While previous literature highlights differences …

Background Progress towards understanding the aetiology of major depression is compromised
by its clinical heterogeneity. The variety of contexts underlying the development of a …

BackgroundMajor depression (MD) is often characterised as a categorical disorder; however,
observational studies comparing sub-threshold and clinical depression suggest MD is …

Genetic studies in psychiatry have primarily focused on the effects of common genetic
variants, but few have investigated the role of rare genetic variants, particularly for major …

Substantial advances have been made in identifying genetic contributions to depression, but
little is known about how the effect of genes can be modulated by the environment, creating …

Diagnostic criteria for major depressive disorder allow for heterogeneous symptom profiles
but genetic analysis of major depressive symptoms has the potential to identify clinical and …

Progress towards understanding the etiology of major depression (MD) is compromised by
its clinical heterogeneity. The variety of contexts underlying the development of a major …

Determining a diagnosis of major depressive disorder (MDD) is complex, involving consideration
and rating of a variety of different components. These include number of symptoms …

… The work presented in this thesis was carried out and written by Bradley Scott Jermy with …
Finally, I demonstrate the importance of considering the context of an individual’s depressive …

There are currently no disease-modifying treatments for Alzheimer’s disease (AD), and an
understanding of preclinical causal biomarkers to help target disease pathogenesis in the …